Phase II study of docetaxel–vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer

Gerasimos Aravantinos; Dimitrios Bafaloukos; George Fountzilas; Christos Christodoulou; Christos Papadimitriou; N Pavlidis; Haralabos P. Kalofonos; Helen Gogas; P. Kosmidis; Meletios A Dimopoulos

doi:10.1093/annonc/mdg292

Related publications

Article1999

Docetaxel-vinorelbine combination for platinum resistant paclitaxel pretreated ovarian cancer. A hellenic co-operative oncology group phase II study

Gerasimos Aravantinos, Dimitrios Bafaloukos, Meletios A Dimopoulos, C. Nikolaides, Pavlos Papakostas, Christos Kiamouris, K. Sikiotis, T. Rapsomaniki, George Fountzilas, D. Skarlos

Article2000

Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer

Gerasimos Aravantinos, Meletios A Dimopoulos, P Kosmidis, Dimitrios Bafaloukos, Christos Papadimitriou, Christos Kiamouris, N. Pavlidis, K. Sikiotis, Pavlos Papakostas, D. Skarlos

Article2006

Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma

George Bozas, Aristotle Bamias, Vassiliki Koutsoukou, Eleni Efstathiou, Dimitra Gika, Christos Papadimitriou, Meletios A Dimopoulos

Article2002

First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study.

D. Pectasides, Meletios A Dimopoulos, Gerasimos Aravantinos, H. P. Kalophonos, P. Papacostas, Evangelos Briasoulis, E. Cogas, C Papadimitriou, D. Skarlos, P. Kosmidis, George Fountzilas

Preprint2021

Pembrolizumab in Combination with Bevacizumab and Oral Cyclophosphamide in Heavily Pretreated Platinum-Resistant Ovarian Cancer

Αngeliki Andrikopoulou, Michalis Liontos, Efthymia Skafida, Konstantinos Koutsoukos, Kleoniki Apostolidou, Μαρία Καπαρέλου, Angeliki Rouvalis, Garyfallia Bletsa, Meletios A Dimopoulos, Flora Zagouri